Results 91 to 100 of about 1,250 (185)

Splicing mutations: making sense with antisense therapy [PDF]

open access: yes, 2012
Tese de mestrado. Biologia (Biologia Molecular e Genética). Universidade de Lisboa, Faculdade de Ciências, 2012Galactose-1-phosphate uridylyltransferase (GALT) transfers a UMP group from UDP-glucose to Gal1P in the second step of the Leloir pathway for ...
Lourenço, Sílvia Pires, 1990-
core  

PO07 | Liver transplant in a case of congenital afibrinogenemia

open access: yesBleeding, Thrombosis and Vascular Biology
Background: Fibrinogen (FBG) is involved in the final steps of coagulation as a precursor of fibrin monomers. Inherited FBG disorders are generally classified as quantitative or qualitative.
doaj   +1 more source

Frequency of Adverse Maternal and Neonatal Outcomes in Patients with Low Serum Fibrinogen Level and Placental Abruption [PDF]

open access: yes, 2018
Objective: To assess frequency of adverse maternal and neonatal outcomes in patients with low serum fibrinogen level and placental abruption.Place and duration: It was held in Gynecology Department Nishtar Hospital Multan from 12 November 2017 to 25 July
Bhatti, Hina Javaid   +2 more
core   +1 more source

Liver transplantation as a novel strategy for resolution of congenital afibrinogenemia in a pediatric patient. [PDF]

open access: yesJ Thromb Haemost, 2020
Corrales-Medina FF   +5 more
europepmc   +1 more source

Une myosine à contre-sens [PDF]

open access: yes, 2006
Bahloul, Amel   +2 more
core   +1 more source

P130 | LIVER TRANSPLANT IN CONGENITAL AFIBRINOGENEMIA: A CASE REPORT

open access: yesHaematologica
Background: Fibrinogen (FBG) is involved in the final steps of coagulation as a precursor of fibrin monomers. Inherited FBG disorders are generally classified as quantitative or qualitative. Quantitative disorders include afibrinogenemia (aFBG), which is
G. Murante   +12 more
doaj  

[Congenital afibrinogenemia: about a case]. [PDF]

open access: yesPan Afr Med J, 2016
Assani K, Karboubi L, Dakhama BS.
europepmc   +1 more source

Home - About - Disclaimer - Privacy